ADVERTISEMENT
Sun Pharma - Non-Compliance Letter On Mohali Facility; Worst Case Expect 2-3% Earnings Hit: Systematix
Site transfer of products may be an option but technical, regulatory challenges in the process cannot be ruled out.
25 Apr 2023, 08:31 AM IST 
Save
A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai. (Photo: Francis Mascarenhas/Reuters)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
